Navigation Links
A potential therapeutic agent for hepatic fibrosis
Date:8/25/2009

Accumulating evidence suggests that connective tissue growth factor (CCN2) plays a central role in fibrotic conditions in many organ systems. Fibrosis is a scarring condition that is characterized by excessive collagen production that impedes normal cell function and can cause organ dysfunction and failure. A hallmark of fibrosing injury in the liver is the activation of hepatic stellate cells (HSCs) which become highly proliferative, synthesize increased levels of transforming growth factor (TGF)-β and CCN2, and produce excessive amounts of collagen. Previous studies have not investigated the effect of CCN2 antagonism in HSCs of human origin.

A research team led by Dr. David Brigstock addresses this question. Their work will be published on August 14, 2009 in World Journal of Gastroenterology.

By designing a novel antisense inhibitor that blocked CCN2 mRNA transcription and protein production, the investigators showed that in activated human HSCs, basal or TGF-β1-induced transcription and production of collagen I could be reduced, and the ability of the cells to actively divide was curtailed. The innovative features of this study involve the use of human HSCs and the delivery of the antisense molecule in the form of a hammerhead ribozyme, which has a more efficient blocking action than some other conventional antisense methods. The data show that the anti-fibrotic properties of CCN2 hammerhead ribozyme are to the result of a reduction of collagen production and cell proliferation.

The results suggest that CCN2 hammerhead ribozyme has utility as a therapeutic agent for treating hepatic fibrosis in vitro. This is important as therapy for liver fibrosis is currently lacking despite the fact that millions of individuals around the world suffer from liver fibrosis caused by hepatitis, alcohol consumption, and other types of chronic liver injury.


'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
0086-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Herb Shows Potential for Rheumatoid Arthritis
2. Hissey Kientz, LLP Warns Duragesic Patch Users about Potential Health Risks of Fentanyl Overdose
3. ARKRAY Statement Regarding U.S. Food and Drug Administrations Public Health Notification: Potentially Fatal Errors With GDH-PQQ Glucose Monitoring Technology
4. Researchers identify potential new avenue to attack cancer
5. OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma
6. Frost & Sullivan: Outsourcing/Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market
7. Large Majority of Drivers 55 and Older Unaware of Potentially Dangerous Combination of Medications and Driving, Says New AAA Foundation Study
8. New class of compounds discovered for potential Alzheimers disease drug
9. Consumer Reports Swine Flu Survival Kit Prepares Consumers for Potentially Tough Flu Season This Fall
10. Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs
11. Hard to Treat Diseases (HTDS) To Re Release European TV Segment In N. America For Potential Treatment Of MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... March 01, 2017 , ... Physicians’ ... on April 8, 2017, in Sunny Isles Beach, Florida. The conference will be ... Physicians Organization, Boston, and Dr. Heather Wakelee, associate professor of medicine (oncology), Stanford ...
(Date:3/1/2017)... Texas (PRWEB) , ... March 01, 2017 , ... Hennessey Performance (HPE) today announced its ... bumped the Ford EcoBoost 3.5L twin turbo V6 engine from 450 bhp and 510 lb-ft ... twist yield a 0-60 mph time of just 4.2 seconds while running down the ¼ ...
(Date:3/1/2017)... ... 01, 2017 , ... Financial Recovery Group, Inc. (FRG), is proud to announce ... Nashville, Tenn. The company also is offering a special discount for those who attend ... year, brings together the brightest minds in the healthcare industry to share information on ...
(Date:3/1/2017)... ... , ... Look for a new collection of edible berry plants from the ... and Plants is launching their new Bushel and Berry Collection , formerly BrazelBerries, ... growing fresh fruit simple with a variety of easy-to-grow, low-maintenance container berry plants. These ...
(Date:3/1/2017)... ... ... On January 27, 2017, Laffey, Bucci & Kent together with a local ... Circuit Court of Kanawha County, West Virginia. The lawsuit was filed on behalf of ... and T.B. v. Seventh-Day Adventist Church et al. Case #: 17-C-146. , ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... PRUSSIA, Pa. , March 1, 2017  Global ... it has completed the largest ever Chronic Inflammatory Demyelinating ... A nd T reatment with H ... designed to demonstrate the efficacy, safety and tolerability of ... Hizentra ® (Immune Globulin Subcutaneous [Human]), compared with ...
(Date:3/1/2017)... Pharmaceutical Care Management Association (PCMA) issued the following statement ... nomination of Seema Verma as the new ... "The popular Medicare Part D program continues to ... offering an abundance of competing plan choices in each ... and home delivery, the program is a win-win for ...
(Date:3/1/2017)... global  Intraoperative Neuromonitoring (IONM) market  is expected to reach USD 3.6 billion by ... neuromonitoring market is anticipated to witness significant growth in the forecast period, which ... of surgeries. Continue Reading ... ... ...
Breaking Medicine Technology: